Quick Facts at a Glance
- Recall Date
- September 22, 2025
- Hazard Level
- HIGH
- Brand
- RC Outsourcing
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL, PREGNANT, GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- RC Outsourcing
- Product type
- Bevacizumab Intravitreal Syringe (0.25 mL; 1.75 mg/0.07 mL)
- Model numbers
- 20250708-768A26, 20250715-944DF2, 20250722-55C603, 20250722-5DC113
- Sold at
- Multiple Retailers
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
September 22, 2025
Reported by FDA DRUG
October 15, 2025
RecallRadar source check
April 18, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Lack of assurance of sterility.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact RC Outsourcing, LLC or your healthcare provider for guidance. Notification method: Letter
About This Product
Bevacizumab intravitreal injections are used to treat retinal diseases in adults and are prepared for hospital or office use. They are administered by ophthalmologists in a clinical setting.
Why This Is Dangerous
A lack of sterility can result in contamination and eye infections, including serious conditions like endophthalmitis, requiring medical care.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Hospitals and clinics must review stock, pause administrations, and coordinate with suppliers. The recall involves 2,669 syringes distributed nationwide, potentially affecting patient care workflows and budgets.
Practical Guidance
How to identify if yours is affected
- Check lot numbers on packaging and syringes against the recalled lots: 20250708-768A26, 20250715-944DF2, 20250722-55C603, 20250722-5DC113.
- Inspect remaining stock to ensure no recalled lots remain in use.
- Quarantine any implicated lots per facility protocol.
- Communicate with RC Outsourcing LLC for instructions and record all steps taken.
Where to find product info
FDA enforcement page for D-0003-2026 and recall notices: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0003-2026
What timeline to expect
Recall processing timelines vary; follow RC Outsourcing guidance. Typical recall-related refunds or replacements, when offered, can take several weeks
If the manufacturer is unresponsive
- Escalate to FDA MedWatch for safety concerns.
- Document all communications and consider legal counsel if needed.
How to prevent similar issues
- Verify sterile, FDA-licensed suppliers for intravitreal medications.
- Require traceability of lots and date codes for all ophthalmic injections.
- Maintain strict cold-chain handling for refrigerated products.
- Establish a single point of contact in purchasing for recalls to speed action.
Documentation advice
Retain all recall notices, packaging photos, lot numbers, communication with RC Outsourcing LLC, and records of stock disposition.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Bevacizumab intravitreal syringe, 0.25 mL total volume (1.75 mg/0.07 mL). Lot numbers being recalled: 20250708-768A26, 20250715-944DF2, 20250722-55C603, 20250722-5DC113. Sold to hospitals and clinics nationwide in the United States. Recall date: 2025-09-22. Quantity: 2,669 syringes. Price: Unknown.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
- Distributed nationwide to hospitals/clinics
- Sterility concerns require immediate action
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
